Daniel A. Maxenberger Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Daniel A. Maxenberger's research focuses on the application of CRISPR-Cas9 genome editing technology. His work investigates challenges related to the delivery of CRISPR-Cas9 for genetic disorders, specifically mentioning Duchenne muscular dystrophy. Maxenberger also explores methods to optimize the expression of Cas9 proteins, aiming for enhanced purification and improved genome editing capabilities, as demonstrated in studies utilizing E. coli BL21(DE3) strains. His research network includes collaborators such as Christopher E. Nelson, Made Harumi Padmaswari, Shilpi Agrawal, and Allie Ivy, all affiliated with the University of Arkansas at Fayetteville, with whom he has co-authored multiple publications. Maxenberger has a publication record of two papers and has accumulated 15 citations, with an h-index of 2.
Metrics
- h-index: 2
- Publications: 2
- Citations: 19
Selected Publications
-
Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing (2024)
-
Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy (2023)
Collaboration Network
Top Collaborators
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
- Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing
Similar Researchers
Based on overlapping research topics